{"count":220314,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1345","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1343","results":[{"created":"2021-04-22T21:22:51.322571+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7275","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GTF2E2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GTF2E2","entity_type":"gene"},{"created":"2021-04-22T21:22:35.465593+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7274","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GTF2E2 as Amber List (moderate evidence)","entity_name":"GTF2E2","entity_type":"gene"},{"created":"2021-04-22T21:22:35.455772+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7274","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gtf2e2 has been classified as Amber List (Moderate Evidence).","entity_name":"GTF2E2","entity_type":"gene"},{"created":"2021-04-22T21:22:18.911603+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7273","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GTF2E2: Rating: AMBER; Mode of pathogenicity: None; Publications: 26996949; Phenotypes: Trichothiodystrophy 6, nonphotosensitive, MIM# 616943, MONDO:0014841; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GTF2E2","entity_type":"gene"},{"created":"2021-04-22T21:21:40.588760+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.123","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GTF2E2 were changed from Trichothiodystrophy 6, nonphotosensitive, MIM# 616943 to Trichothiodystrophy 6, nonphotosensitive, MIM# 616943; MONDO:0014841","entity_name":"GTF2E2","entity_type":"gene"},{"created":"2021-04-22T21:20:56.587850+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.122","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GTF2E2 as ready","entity_name":"GTF2E2","entity_type":"gene"},{"created":"2021-04-22T21:20:56.578078+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.122","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gtf2e2 has been classified as Amber List (Moderate Evidence).","entity_name":"GTF2E2","entity_type":"gene"},{"created":"2021-04-22T21:20:53.399686+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.122","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GTF2E2 were changed from  to Trichothiodystrophy 6, nonphotosensitive, MIM# 616943","entity_name":"GTF2E2","entity_type":"gene"},{"created":"2021-04-22T21:20:31.194274+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.121","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GTF2E2 were set to ","entity_name":"GTF2E2","entity_type":"gene"},{"created":"2021-04-22T21:19:54.701769+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.120","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GTF2E2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GTF2E2","entity_type":"gene"},{"created":"2021-04-22T21:19:27.405932+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.119","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GTF2E2 as Amber List (moderate evidence)","entity_name":"GTF2E2","entity_type":"gene"},{"created":"2021-04-22T21:19:27.396787+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.119","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gtf2e2 has been classified as Amber List (Moderate Evidence).","entity_name":"GTF2E2","entity_type":"gene"},{"created":"2021-04-22T21:18:56.891501+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.118","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GTF2E2: Rating: AMBER; Mode of pathogenicity: None; Publications: 26996949; Phenotypes: Trichothiodystrophy 6, nonphotosensitive, MIM# 616943; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GTF2E2","entity_type":"gene"},{"created":"2021-04-22T21:03:47.023251+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.118","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TYR as ready","entity_name":"TYR","entity_type":"gene"},{"created":"2021-04-22T21:03:47.013123+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.118","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tyr has been classified as Red List (Low Evidence).","entity_name":"TYR","entity_type":"gene"},{"created":"2021-04-22T21:03:36.020737+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.118","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TYR were changed from  to Albinism, oculocutaneous, type IA, MIM# 203100","entity_name":"TYR","entity_type":"gene"},{"created":"2021-04-22T21:03:18.570647+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.117","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TYR was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"TYR","entity_type":"gene"},{"created":"2021-04-22T21:02:55.529983+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.116","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TYR as Red List (low evidence)","entity_name":"TYR","entity_type":"gene"},{"created":"2021-04-22T21:02:55.520914+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.116","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tyr has been classified as Red List (Low Evidence).","entity_name":"TYR","entity_type":"gene"},{"created":"2021-04-22T21:02:24.598382+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.115","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: TYR: Changed mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"TYR","entity_type":"gene"},{"created":"2021-04-22T21:02:16.422080+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.115","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TYR: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Albinism, oculocutaneous, type IA, MIM# 203100; Mode of inheritance: None","entity_name":"TYR","entity_type":"gene"},{"created":"2021-04-22T20:58:59.256345+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.115","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SLX4 as ready","entity_name":"SLX4","entity_type":"gene"},{"created":"2021-04-22T20:58:59.247055+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.115","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: slx4 has been classified as Green List (High Evidence).","entity_name":"SLX4","entity_type":"gene"},{"created":"2021-04-22T20:58:53.492818+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.115","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: SLX4 were set to ","entity_name":"SLX4","entity_type":"gene"},{"created":"2021-04-22T20:58:30.519315+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.114","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SLX4 were changed from  to Fanconi anemia, complementation group P, MIM# 613951; MONDO:0013499","entity_name":"SLX4","entity_type":"gene"},{"created":"2021-04-22T20:58:02.605569+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.113","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: SLX4 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"SLX4","entity_type":"gene"},{"created":"2021-04-22T20:57:11.880031+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.112","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RAD51C as ready","entity_name":"RAD51C","entity_type":"gene"},{"created":"2021-04-22T20:57:11.869058+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.112","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rad51c has been classified as Green List (High Evidence).","entity_name":"RAD51C","entity_type":"gene"},{"created":"2021-04-22T20:57:06.638338+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.112","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RAD51C were changed from  to Fanconi anemia, complementation group O, MIM# 613390","entity_name":"RAD51C","entity_type":"gene"},{"created":"2021-04-22T20:56:24.989347+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.111","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: RAD51C were set to ","entity_name":"RAD51C","entity_type":"gene"},{"created":"2021-04-22T20:55:57.585947+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.110","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: RAD51C was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"RAD51C","entity_type":"gene"},{"created":"2021-04-22T20:54:34.261621+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.215","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCL as ready","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:54:34.232502+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.215","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fancl has been classified as Green List (High Evidence).","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:54:27.689498+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.215","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCL were changed from  to Fanconi anemia, complementation group L, MIM# 614083; MONDO:0013566","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:54:05.393662+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.214","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FANCL were set to ","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:53:38.892499+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.213","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FANCL was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:53:08.615039+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.212","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FANCL: Rating: GREEN; Mode of pathogenicity: None; Publications: 19405097, 25754594, 33394227, 33224012; Phenotypes: Fanconi anemia, complementation group L, MIM# 614083, MONDO:0013566; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:53:00.189219+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCL as ready","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:53:00.178988+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fancl has been classified as Green List (High Evidence).","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:52:52.036834+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCL were changed from  to Fanconi anemia, complementation group L, MIM# 614083; MONDO:0013566","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:52:21.243927+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7273","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCL as ready","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:52:21.229186+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7273","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fancl has been classified as Green List (High Evidence).","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:52:13.530454+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7273","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCL were changed from  to Fanconi anemia, complementation group L, MIM# 614083; MONDO:0013566","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:51:57.231000+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7272","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FANCL were set to ","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:51:39.572429+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7271","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FANCL was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:51:23.313446+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.108","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FANCL were set to ","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:51:20.072908+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7270","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FANCL: Rating: GREEN; Mode of pathogenicity: None; Publications: 19405097, 25754594, 33394227, 33224012; Phenotypes: Fanconi anemia, complementation group L, MIM# 614083, MONDO:0013566; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:50:50.100925+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.107","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FANCL was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:50:20.847679+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.106","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FANCL: Rating: GREEN; Mode of pathogenicity: None; Publications: 19405097, 25754594, 33394227, 33224012; Phenotypes: Fanconi anemia, complementation group L, MIM# 614083, MONDO:0013566; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCL","entity_type":"gene"},{"created":"2021-04-22T20:47:26.697189+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.212","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCI as ready","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:47:26.687034+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.212","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fanci has been classified as Green List (High Evidence).","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:47:23.562036+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.212","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCI were changed from  to Fanconi anemia, complementation group I, MIM# 609053; MONDO:0012186","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:46:58.412283+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.211","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FANCI were set to ","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:46:36.704571+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.210","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FANCI was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:46:11.471594+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.209","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FANCI: Rating: GREEN; Mode of pathogenicity: None; Publications: 17452773; Phenotypes: Fanconi anemia, complementation group I, MIM# 609053, MONDO:0012186; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:15:10.716098+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7270","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCI as ready","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:15:10.706083+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7270","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fanci has been classified as Green List (High Evidence).","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:15:02.897021+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7270","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCI were changed from  to Fanconi anemia, complementation group I, MIM# 609053; MONDO:0012186","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:14:42.407456+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7269","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FANCI were set to ","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:13:47.444803+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7268","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FANCI was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:13:27.663507+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7267","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FANCI: Rating: GREEN; Mode of pathogenicity: None; Publications: 17452773; Phenotypes: Fanconi anemia, complementation group I, MIM# 609053, MONDO:0012186; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:12:26.067108+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.106","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCI as ready","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:12:26.056996+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.106","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fanci has been classified as Green List (High Evidence).","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:12:22.475344+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.106","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCI were changed from  to Fanconi anemia, complementation group I, MIM# 609053; MONDO:0012186","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:11:59.734606+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.105","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FANCI were set to ","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:11:25.864648+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.104","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FANCI was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T20:10:49.314056+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.103","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FANCI: Rating: GREEN; Mode of pathogenicity: None; Publications: 17452773; Phenotypes: Fanconi anemia, complementation group I, MIM# 609053, MONDO:0012186; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCI","entity_type":"gene"},{"created":"2021-04-22T14:00:42.480027+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7267","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCG as ready","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-04-22T14:00:42.469306+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7267","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fancg has been classified as Green List (High Evidence).","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-04-22T14:00:30.938636+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7267","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCG were changed from  to Fanconi anaemia, complementation group G, MIM# 614082; MONDO:0013565","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-04-22T14:00:12.693586+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7266","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FANCG were set to ","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-04-22T13:59:50.484067+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7265","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FANCG was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-04-22T13:59:31.523314+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7264","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FANCG: Rating: GREEN; Mode of pathogenicity: None; Publications: 9806548, 12552564; Phenotypes: Fanconi anaemia, complementation group G, MIM# 614082, MONDO:0013565; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-04-22T13:58:14.953985+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.103","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCG as ready","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-04-22T13:58:14.931384+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.103","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fancg has been classified as Green List (High Evidence).","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-04-22T13:58:11.442926+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.103","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCG were changed from  to Fanconi anaemia, complementation group G, MIM# 614082; MONDO:0013565","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-04-22T13:57:41.495231+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.102","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FANCG were set to ","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-04-22T13:57:17.068213+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.101","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FANCG was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-04-22T13:56:40.858811+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.100","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FANCG: Rating: GREEN; Mode of pathogenicity: None; Publications: 9806548, 12552564; Phenotypes: Fanconi anaemia, complementation group G, MIM# 614082, MONDO:0013565; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCG","entity_type":"gene"},{"created":"2021-04-22T13:50:43.206242+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7264","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCF as ready","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-04-22T13:50:43.192070+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7264","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fancf has been classified as Green List (High Evidence).","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-04-22T13:50:27.923174+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7264","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCF were changed from  to Fanconi anaemia, complementation group F 603467; MONDO:0011325","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-04-22T13:48:46.400973+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7263","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FANCF were set to ","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-04-22T13:48:21.180362+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7262","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FANCF was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-04-22T13:48:03.618967+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7261","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FANCF: Rating: GREEN; Mode of pathogenicity: None; Publications: 10615118, 31288759; Phenotypes: Fanconi anaemia, complementation group F 603467, MONDO:0011325; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-04-22T13:44:02.261101+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.100","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCF as ready","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-04-22T13:44:02.251006+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.100","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fancf has been classified as Green List (High Evidence).","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-04-22T13:43:40.315486+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.100","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCF were changed from  to Fanconi anaemia, complementation group F 603467; MONDO:0011325","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-04-22T13:43:11.430212+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.99","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FANCF were set to ","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-04-22T13:42:47.340843+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.98","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FANCF was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-04-22T13:42:21.034797+10:00","panel_name":"Chromosome Breakage Disorders","panel_id":79,"panel_version":"0.97","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FANCF: Rating: GREEN; Mode of pathogenicity: None; Publications: 10615118, 31288759; Phenotypes: Fanconi anaemia, complementation group F 603467, MONDO:0011325; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCF","entity_type":"gene"},{"created":"2021-04-22T13:36:46.449995+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.209","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCE as ready","entity_name":"FANCE","entity_type":"gene"},{"created":"2021-04-22T13:36:46.439571+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.209","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fance has been classified as Green List (High Evidence).","entity_name":"FANCE","entity_type":"gene"},{"created":"2021-04-22T13:36:43.789234+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.209","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCE were changed from  to Fanconi anaemia, complementation group E, MIM# 600901; MONDO:0010953","entity_name":"FANCE","entity_type":"gene"},{"created":"2021-04-22T13:36:15.781724+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.208","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FANCE were set to ","entity_name":"FANCE","entity_type":"gene"},{"created":"2021-04-22T13:35:50.643334+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.207","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FANCE was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCE","entity_type":"gene"},{"created":"2021-04-22T13:35:11.025946+10:00","panel_name":"Bone Marrow Failure","panel_id":56,"panel_version":"0.206","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FANCE: Rating: GREEN; Mode of pathogenicity: None; Publications: 11001585, 31586946, 7662964, 9382107, 9147877, 10205272; Phenotypes: Fanconi anaemia, complementation group E, MIM# 600901, MONDO:0010953; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FANCE","entity_type":"gene"},{"created":"2021-04-22T13:33:13.954156+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7261","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FANCE as ready","entity_name":"FANCE","entity_type":"gene"},{"created":"2021-04-22T13:33:13.943740+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7261","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fance has been classified as Green List (High Evidence).","entity_name":"FANCE","entity_type":"gene"},{"created":"2021-04-22T13:33:06.681872+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7261","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FANCE were changed from  to Fanconi anaemia, complementation group E, MIM# 600901; MONDO:0010953","entity_name":"FANCE","entity_type":"gene"}]}